JPS6238A - 混合ビタミン凍結乾燥製剤の製法 - Google Patents
混合ビタミン凍結乾燥製剤の製法Info
- Publication number
- JPS6238A JPS6238A JP61045708A JP4570886A JPS6238A JP S6238 A JPS6238 A JP S6238A JP 61045708 A JP61045708 A JP 61045708A JP 4570886 A JP4570886 A JP 4570886A JP S6238 A JPS6238 A JP S6238A
- Authority
- JP
- Japan
- Prior art keywords
- freeze
- castor oil
- vitamin
- mixed vitamin
- injection
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000013343 vitamin Nutrition 0.000 title claims abstract description 27
- 239000011782 vitamin Substances 0.000 title claims abstract description 27
- 229930003231 vitamin Natural products 0.000 title claims abstract description 27
- 229940088594 vitamin Drugs 0.000 title claims abstract description 27
- 150000003722 vitamin derivatives Chemical class 0.000 title claims abstract description 14
- 238000004519 manufacturing process Methods 0.000 title claims description 7
- 239000004359 castor oil Substances 0.000 claims abstract description 13
- 235000019438 castor oil Nutrition 0.000 claims abstract description 13
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 claims abstract description 13
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 12
- 239000004094 surface-active agent Substances 0.000 claims abstract description 12
- -1 polyoxypropylene Polymers 0.000 claims abstract description 8
- 239000002736 nonionic surfactant Substances 0.000 claims abstract description 7
- 150000003904 phospholipids Chemical class 0.000 claims abstract description 7
- 229920001451 polypropylene glycol Polymers 0.000 claims abstract description 5
- 238000002360 preparation method Methods 0.000 claims description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 abstract description 15
- 239000007924 injection Substances 0.000 abstract description 11
- 238000002347 injection Methods 0.000 abstract description 11
- 239000000243 solution Substances 0.000 abstract description 10
- 239000012153 distilled water Substances 0.000 abstract description 7
- JQWAHKMIYCERGA-UHFFFAOYSA-N (2-nonanoyloxy-3-octadeca-9,12-dienoyloxypropoxy)-[2-(trimethylazaniumyl)ethyl]phosphinate Chemical compound CCCCCCCCC(=O)OC(COP([O-])(=O)CC[N+](C)(C)C)COC(=O)CCCCCCCC=CCC=CCCCCC JQWAHKMIYCERGA-UHFFFAOYSA-N 0.000 abstract description 4
- RVGRUAULSDPKGF-UHFFFAOYSA-N Poloxamer Chemical compound C1CO1.CC1CO1 RVGRUAULSDPKGF-UHFFFAOYSA-N 0.000 abstract description 3
- 229920001993 poloxamer 188 Polymers 0.000 abstract description 3
- KILNVBDSWZSGLL-KXQOOQHDSA-N 1,2-dihexadecanoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCCCCCCCCCC KILNVBDSWZSGLL-KXQOOQHDSA-N 0.000 abstract description 2
- JLPULHDHAOZNQI-ZTIMHPMXSA-N 1-hexadecanoyl-2-(9Z,12Z-octadecadienoyl)-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCCCCCC\C=C/C\C=C/CCCCC JLPULHDHAOZNQI-ZTIMHPMXSA-N 0.000 abstract description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 abstract description 2
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 abstract description 2
- 239000008103 glucose Substances 0.000 abstract description 2
- 239000002504 physiological saline solution Substances 0.000 abstract description 2
- 229940083466 soybean lecithin Drugs 0.000 abstract description 2
- 239000000126 substance Substances 0.000 abstract description 2
- 238000000034 method Methods 0.000 description 8
- UIIMBOGNXHQVGW-UHFFFAOYSA-M Sodium bicarbonate Chemical compound [Na+].OC([O-])=O UIIMBOGNXHQVGW-UHFFFAOYSA-M 0.000 description 4
- 238000012360 testing method Methods 0.000 description 4
- 230000006866 deterioration Effects 0.000 description 3
- 238000004108 freeze drying Methods 0.000 description 3
- FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 3
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 2
- 229920002307 Dextran Polymers 0.000 description 2
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 description 2
- 241000700159 Rattus Species 0.000 description 2
- JYYOBHFYCIDXHH-UHFFFAOYSA-N carbonic acid;hydrate Chemical compound O.OC(O)=O JYYOBHFYCIDXHH-UHFFFAOYSA-N 0.000 description 2
- 230000000052 comparative effect Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 description 2
- 238000001802 infusion Methods 0.000 description 2
- 229940067606 lecithin Drugs 0.000 description 2
- 235000010445 lecithin Nutrition 0.000 description 2
- 239000000787 lecithin Substances 0.000 description 2
- 229910000030 sodium bicarbonate Inorganic materials 0.000 description 2
- 235000017557 sodium bicarbonate Nutrition 0.000 description 2
- ASWBNKHCZGQVJV-UHFFFAOYSA-N (3-hexadecanoyloxy-2-hydroxypropyl) 2-(trimethylazaniumyl)ethyl phosphate Chemical compound CCCCCCCCCCCCCCCC(=O)OCC(O)COP([O-])(=O)OCC[N+](C)(C)C ASWBNKHCZGQVJV-UHFFFAOYSA-N 0.000 description 1
- QFMZQPDHXULLKC-UHFFFAOYSA-N 1,2-bis(diphenylphosphino)ethane Chemical compound C=1C=CC=CC=1P(C=1C=CC=CC=1)CCP(C=1C=CC=CC=1)C1=CC=CC=C1 QFMZQPDHXULLKC-UHFFFAOYSA-N 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 description 1
- 206010055024 Pancreatic enlargement Diseases 0.000 description 1
- 229930003270 Vitamin B Natural products 0.000 description 1
- 239000012190 activator Substances 0.000 description 1
- 230000032683 aging Effects 0.000 description 1
- 238000009833 condensation Methods 0.000 description 1
- 230000005494 condensation Effects 0.000 description 1
- 229940119744 dextran 40 Drugs 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 229960000304 folic acid Drugs 0.000 description 1
- 235000019152 folic acid Nutrition 0.000 description 1
- 239000011724 folic acid Substances 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- XSEOYPMPHHCUBN-FGYWBSQSSA-N hydroxylated lecithin Chemical compound CCCCCCCCCCCCCCCCCC(=O)OC(COP([O-])(=O)OCC[N+](C)(C)C)COC(=O)CCCCCCC[C@@H](O)[C@H](O)CCCCCCCC XSEOYPMPHHCUBN-FGYWBSQSSA-N 0.000 description 1
- 238000001990 intravenous administration Methods 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 210000004072 lung Anatomy 0.000 description 1
- 230000007721 medicinal effect Effects 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 235000005152 nicotinamide Nutrition 0.000 description 1
- 239000011570 nicotinamide Substances 0.000 description 1
- 231100000957 no side effect Toxicity 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 210000000496 pancreas Anatomy 0.000 description 1
- 229920001983 poloxamer Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000003393 splenic effect Effects 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7135—Compounds containing heavy metals
- A61K31/714—Cobalamins, e.g. cyanocobalamin, i.e. vitamin B12
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/44—Oils, fats or waxes according to two or more groups of A61K47/02-A61K47/42; Natural or modified natural oils, fats or waxes, e.g. castor oil, polyethoxylated castor oil, montan wax, lignite, shellac, rosin, beeswax or lanolin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Obesity (AREA)
- Dermatology (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Nutrition Science (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Molecular Biology (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP60-48880 | 1985-03-12 | ||
| JP4888085 | 1985-03-12 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JPS6238A true JPS6238A (ja) | 1987-01-06 |
| JPH0586766B2 JPH0586766B2 (enrdf_load_stackoverflow) | 1993-12-14 |
Family
ID=12815597
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP61045708A Granted JPS6238A (ja) | 1985-03-12 | 1986-03-03 | 混合ビタミン凍結乾燥製剤の製法 |
Country Status (6)
| Country | Link |
|---|---|
| EP (1) | EP0194880B1 (enrdf_load_stackoverflow) |
| JP (1) | JPS6238A (enrdf_load_stackoverflow) |
| AT (1) | ATE60505T1 (enrdf_load_stackoverflow) |
| CA (1) | CA1305668C (enrdf_load_stackoverflow) |
| DE (1) | DE3677238D1 (enrdf_load_stackoverflow) |
| ES (1) | ES8704178A1 (enrdf_load_stackoverflow) |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4901556A (en) * | 1986-12-06 | 1990-02-20 | Pfd Limited | Loading a segmented die and ejecting a component formed therein |
| JPH02243617A (ja) * | 1988-04-15 | 1990-09-27 | Iatron Lab Inc | 非水溶性物質の透明な水溶液が得られる凍結乾燥品の製造方法 |
| US5536544A (en) * | 1992-09-07 | 1996-07-16 | Liegeois; Jean M. | Flexible or rigid combinations of materials in composite form which are formable and adhesive at temperatures below 90° C. |
| JP2005075804A (ja) * | 2003-09-03 | 2005-03-24 | Toyo Capsule Kk | メナテトレノン含有医薬組成物 |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| TWI225402B (en) | 1996-03-13 | 2004-12-21 | Biochemie Gmbh | Auxiliary-free agglomerates |
| TR200000529T2 (tr) * | 1997-08-29 | 2000-08-21 | Dsm N.V. | İçinde eksipiyan olmayan granüller |
| CN101711769A (zh) * | 2009-11-23 | 2010-05-26 | 北京京卫信康医药科技发展有限公司 | 一种稳定的注射用12种复合维生素组合物及其制备方法 |
| CN105919951B (zh) * | 2016-06-19 | 2019-08-30 | 成都天台山制药有限公司 | 注射用水溶性维生素与脂溶性维生素ii的药物组合 |
| CN105997898B (zh) * | 2016-06-19 | 2019-08-30 | 成都天台山制药有限公司 | 注射用脂溶性维生素i粉针剂组合物和制法 |
Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5298689A (en) * | 1976-02-12 | 1977-08-18 | Ici Ltd | Method of manufacturing solutions of practically waterrinsoluble compounds |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3070499A (en) * | 1960-09-19 | 1962-12-25 | Merck & Co Inc | Parenteral aqueous solutions of fat soluble vitamins |
| GB1126289A (en) * | 1966-05-12 | 1968-09-05 | Hoffmann La Roche | Water-dispersible water-free vitamin preparations and a process for the manufacture thereof |
| GB1225979A (enrdf_load_stackoverflow) * | 1967-03-23 | 1971-03-24 | ||
| US4011661A (en) * | 1973-10-30 | 1977-03-15 | Kyowa Hakko Kogyo Co., Ltd. | Powdered emulsion product and method of production |
| DE2441761A1 (de) * | 1974-08-30 | 1976-03-11 | Kohjin Co | Gefriergetrocknete 2,2'-anhydro1-beta-d-arabinofuranosylcytosinsalz-praeparate, verfahren zu ihrer herstellung und injektionspraeparat |
-
1986
- 1986-03-03 JP JP61045708A patent/JPS6238A/ja active Granted
- 1986-03-12 AT AT86301797T patent/ATE60505T1/de not_active IP Right Cessation
- 1986-03-12 ES ES552945A patent/ES8704178A1/es not_active Expired
- 1986-03-12 EP EP86301797A patent/EP0194880B1/en not_active Expired - Lifetime
- 1986-03-12 DE DE8686301797T patent/DE3677238D1/de not_active Expired - Fee Related
- 1986-03-12 CA CA000503939A patent/CA1305668C/en not_active Expired - Fee Related
Patent Citations (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5298689A (en) * | 1976-02-12 | 1977-08-18 | Ici Ltd | Method of manufacturing solutions of practically waterrinsoluble compounds |
Cited By (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4901556A (en) * | 1986-12-06 | 1990-02-20 | Pfd Limited | Loading a segmented die and ejecting a component formed therein |
| JPH02243617A (ja) * | 1988-04-15 | 1990-09-27 | Iatron Lab Inc | 非水溶性物質の透明な水溶液が得られる凍結乾燥品の製造方法 |
| US5536544A (en) * | 1992-09-07 | 1996-07-16 | Liegeois; Jean M. | Flexible or rigid combinations of materials in composite form which are formable and adhesive at temperatures below 90° C. |
| JP2005075804A (ja) * | 2003-09-03 | 2005-03-24 | Toyo Capsule Kk | メナテトレノン含有医薬組成物 |
Also Published As
| Publication number | Publication date |
|---|---|
| ES8704178A1 (es) | 1987-03-16 |
| CA1305668C (en) | 1992-07-28 |
| ATE60505T1 (de) | 1991-02-15 |
| DE3677238D1 (de) | 1991-03-07 |
| EP0194880A3 (en) | 1987-09-02 |
| EP0194880A2 (en) | 1986-09-17 |
| JPH0586766B2 (enrdf_load_stackoverflow) | 1993-12-14 |
| EP0194880B1 (en) | 1991-01-30 |
| ES552945A0 (es) | 1987-03-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| RU2147432C1 (ru) | Эмульсии типа масло в воде, содержащие пропофол и эдетат | |
| US6528067B1 (en) | Total nutrient admixtures as stable multicomponent liquids or dry powders and methods for the preparation thereof | |
| JP2002527465A (ja) | ペンテチン酸塩を含有するプロポフォール組成物 | |
| US4252793A (en) | Injectable lecithin preparation | |
| US20050027019A1 (en) | Aqueous 2,6-diisopropylphenol pharmaceutical compositions | |
| JP2002502811A (ja) | 亜硫酸塩を含有するプロポフォール組成物 | |
| JPS6238A (ja) | 混合ビタミン凍結乾燥製剤の製法 | |
| WO2013151341A1 (en) | Injectable composition comprising phosphatidylcholine and method for preparing thereof | |
| RU2350323C2 (ru) | Способ кардиопротекции и нейропротекции внутривенным введением галогенсодержащего летучего анестезирующего средства | |
| RU2316317C2 (ru) | Составленные на основе воды фармацевтические композиции водорастворимых пролекарств пропофола | |
| KR100520738B1 (ko) | 간염 치료제 | |
| JPS58162517A (ja) | 脂溶性ビタミン含有脂肪乳剤 | |
| JP2003533476A (ja) | 敗血症ショックの治療 | |
| JP2022514991A (ja) | 安定な麻酔薬製剤および関連する剤形 | |
| KR20160117902A (ko) | 포스파티딜콜린 및 리소포스파티딜콜린을 포함하는 주사제용 조성물 및 이의 제조방법 | |
| CN100333722C (zh) | 静脉用棓丙酯的稳定水包油乳剂及其制备方法 | |
| JP3155312B2 (ja) | 安定な静脈注射用総合ビタミン剤 | |
| JPH06256212A (ja) | オーレオバシジン類のリポソーム製剤 | |
| KR20150095772A (ko) | 아토피성 피부염 치료를 위한 피도티모드의 사용 | |
| JPH062664B2 (ja) | 安定な総合ビタミン凍結乾燥製剤 | |
| EP3773467B1 (en) | All-in-one lyophilized multivitamin emulsion for parenteral application | |
| JPS61207327A (ja) | 安定な混合ビタミン凍結乾燥製剤の製法 | |
| Scioli Montoto et al. | Intravenous Administration: Technological Considerations | |
| KR100358244B1 (ko) | 프로포폴 및 에데테이트를 함유하는 수중유 에멀션 | |
| KR100358243B1 (ko) | 프로포폴및에데테이트를함유하는수중유에멀션 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| EXPY | Cancellation because of completion of term |